This comes to us from OTC Daily. My thoughts follow the paste immediately below:
**********************************************************
Brainstorm Cell Therapeutics (OTC: BCLI) continued to hold up right around the 52 week high for the stock at just above $0.37 closing just below that level in trading ahead of Tuesdays open. Intra-day the stock almost went through another 52 week high as stated on our latest penny stocks picks release last week. If Brainstorm keeps trading like this and more importantly holds above the support line in the low $0.30s then shares could go much higher.
**********************************************************
There's a good case for expecting BCLI to break out into higher territory. After all, we're now at a virtual double from the 18 cents we occupied the beginning of January of this year. At the same time, volume is anemic and doesn't make much sense yet.
Things are heating up. The clinical trials are moving along with excitement building along the way. The company has moved conspicuously to take care of loose ends that could seriously damage our prospects for profitability. And while I wouldn't say there have been leaks from within, I sense there have been and continue to be sparks lighting the way to exciting developments.
The publication quoted above (towards the top)does not impress me particularly. I'm always wondering who gets compensated for what and I tend to trust very few when it comes to making investment decisions. In fact, when I'm pulling things together as I'm doing right now, I have to check the mirror to be sure I am me. How else can I trust someone named "Jugs?"
Investment decisions are very highly personal and personalized. Please be sure yours receive their proper level of respect. I've shared my ideas herein, the decisions must be yours.
Best of good fortune to us all!
